SEARCH

SEARCH BY CITATION

References

  • Adell A, Castro E, Celada P, Bortolozzi A, Pazos A, Artigas F (2005). Strategies for producing faster acting antidepressants. Drug Discov Today 10: 578585.
  • Alex KD, Pehek EA (2007). Pharmacologic mechanisms of serotonergic regulation of dopamine neurotransmission. Pharmacol Ther 113: 296320.
  • Alexander SPH, Mathie A, Peters JA (2009). Guide to Receptors and Channels (GRAC), 4th edn. Br J Pharmacol 158 (Suppl. 1): S1S254.
  • Andrade R, Chaput YJ (1991). 5-Hydroxytryptamine4-like receptors mediate the slow excitatory response to serotonin in the rat hippocampus. J Pharmacol Exp Ther 257: 930937.
  • Artaiz I, Zazpe A, Innerarity A, Del Olmo E, Diaz A, Ruiz-Ortega JA et al. (2005). Preclinical pharmacology of F-98214-TA, a novel potent serotonin and norepinephrine uptake inhibitor with antidepressant and anxiolytic properties. Psychopharmacology (Berl) 182: 400413.
  • Beiqüe J-C, De Montigny C, Blier P, Debonnel G (2000a). Effects of sustained administration of the serotonin and norepinephrine reuptake inhibitor venlafaxine: I. In vivo electrophysiological studies in the rat. Neuropharmacology 39: 18001812.
  • Beiqüe J-C, De Montigny C, Blier P, Debonnel G (2000b). Effects of sustained administration of the serotonin and norepinephrine reuptake inhibitor venlafaxine: II. In vitro studies in the rat. Neuropharmacology 39: 18131822.
  • Benmansour S, Altamirano AV, Jones DJ, Sanchez TA, Gould GG, Pardon MC et al. (2004). Regulation of the norepinephrine transporter by chronic administration of antidepressants. Biol Psychiatry 55: 313316.
  • Berg KA, Clarke P (2001). Regulation of 5-HT1A and 5-HT1B receptor systems by phospholipids signalling cascades. Brain Res Bull 56: 471477.
  • Bianchi C, Rodi D, Marino S, Beani L, Siniscalchi A (2002). Dual effects of 5-HT4 receptor activation on GABA release from guinea pig hippocampal slices. Neuroreport 13: 21772180.
  • Bijak M, Tokarski K, Maj J (1997). Repeated treatment with antidepressant drugs induces subsensitivity to the excitatory effect of 5-HT4 receptor activation in the rat hippocampus. Naunyn Schmiedebergs Arch Pharmacol 355: 1419.
  • Bijak M, Zahorodna A, Tokarski K (2001). Opposite effects of antidepressants and corticosterone on the sensitivity of hippocampal CA1 neurons to 5-HT1A and 5-HT4 receptor activation. Naunyn Schmiedebergs Arch Pharmacol 363: 491498.
  • Blier P, De Montigny C (1994). Current advances and trends in the treatment of depression. Trends Pharmacol Sci 15: 220226.
  • Bockaert J, Claeysen S, Compan V, Dumuis A (2004). 5-HT4 receptors. Curr Drug Targets CNS Neurol Disord 3: 3951.
  • Bockaert J, Claeysen S, Compan V, Dumuis A (2008). 5-HT4 receptors: history, molecular pharmacology and brain functions. Neuropharmacology 55: 922931.
  • Bolden-Watson C, Richelson E (1993). Blockade by newly-developed antidepressants of biogenic amine uptake into rat brain synaptosomes. Life Sci 52: 10231029.
  • Brunello N, Mendlewiczc J, Kasperd S, Leonard B, Montgomery S, Nelson J et al. (2002). The role of noradrenaline and selective noradrenaline reuptake inhibition in depression. Eur Neuropsychopharmacol 12: 461475.
  • Bymaster FP, Dreshfield-Ahmad LJ, Threlkeld PG, Shaw JL, Thompson L, Nelson DL et al. (2001). Comparative affinity of duloxetine and venlafaxine for serotonin and norepinephrine transporters in vitro and in vivo, human serotonin receptor subtypes, and other neuronal receptors. Neuropsychopharmacology 25: 871880.
  • Castro ME, Díaz A, Del Olmo E, Pazos A (2003). Chronic fuoxetine induces opposite changes in G protein coupling at pre and postsynaptic 5-HT1A receptors in rat brain. Neuropharmacology 44: 93101.
  • Castro E, Díaz A, Rodríguez-Gaztelumendi A, Del Olmo E, Pazos A (2008). WAY100635 prevents the changes induced by fluoxetine upon the 5-HT1A receptor functionality. Neuropharmacology 55: 13911396.
  • Claeysen S, Sebben M, Becamel C, Bockaert J, Dumuis A (1999). Novel brain-specific 5-HT4 receptor splice variants show marked constitutive activity: role of the C-terminal intracellular domain. Mol Pharmacol 55: 910920.
  • Conductier G, Dusticier N, Lucas G, Cote F, Debonnel G, Daszuta A et al. (2006). Adaptive changes in serotonin neurons of the raphe nuclei in 5-HT4 receptor knock-out mouse. Eur J Neurosci 24: 10531062.
  • Coppen A (1967). The biochemistry of affective disorders. Br J Psychiatry 113: 12371264.
  • Donati RJ, Rasenick MM (2003). G protein signaling and the molecular basis of antidepressant action. Life Sci 73: 117.
  • Dowlatshahi D, MacQueen GM, Wang J-F, Reiach JS, Young LT (1999). G protein-coupled cyclic AMP signaling in postmortem brain of subjects with mood disorders: effects of diagnosis, suicide, and treatment at the time of death. J Neurochem 73: 11211126.
  • Drew MR, Hen R (2007). Adult hippocampal neurogenesis as target for the treatment of depression. CNS Neurol Disord Drug Targets 6: 205218
  • Duman RS, Nakagawa S, Malberg J (2001). Regulation of adult neurogenesis by antidepressant treatment. Neuropsychopharmacology 25: 836844.
  • Fagni L, Dumuis A, Sebben M, Bockaert J (1992). The 5-HT4 receptor subtype inhibits K+ current in colliculi neurones via activation of a cyclic AMP-dependent protein kinase. Br J Pharmacol 105: 973979.
  • Frodl T, Möller HJ, Meisenzahl E (2008). Neuroimaging genetics: new perspectives in research on major depression? Acta Psychiatr Scand 118: 363372
  • Gerald C, Adham N, Kao HT, Olsen MA, Laz TM, Schechter LE et al. (1995). The 5-HT4 receptor: molecular cloning and pharmacological characterization of two splice variants. EMBO J 14: 28062815.
  • Gobbi M, Crespi D, Foddi MC, Fracasso C, Mancini L, Parotti L et al. (1997). Effects of chronic treatment with fluoxetine and citalopram on 5-HT uptake, 5-HT1B autoreceptors, 5-HT3 and 5-HT4 receptors in rats. Naunyn Schmiedebergs Arch Pharmacol 356: 2228.
  • Hensler JG (2002). Differential regulation of 5-HT1A receptor-G protein interactions in brain following chronic antidepressant administration. Neuropsychopharmacology 26: 565573.
  • Hervás I, Vilaró MT, Romero L, Scorza MC, Mengod G, Artigas F (2001). Desensitization of 5-HT1A autoreceptors by a low chronic fluoxetine dose effect of the concurrent administration of WAY-100635. Neuropsychopharmacology 24: 1120.
  • Horschitz S, Hummerich R, Schloss P (2001). Structure, function and regulation of the 5-hydroxytryptamine (serotonin) transporter. Biochem Soc Trans 29: 728732.
  • Hoyer D, Hannon JP, Martin GR (2002). Molecular, pharmacological and functional diversity of 5-HT receptors. Pharmacol Biochem Behav 71: 533554.
  • Hrdina PD, Foy B, Hepner A, Summers RJ (1990). Antidepressant binding sites in brain: autoradiographic comparison of [3H]paroxetine and [3H]imipramine localization and relationship to serotonin transporter. J Pharmacol Exper Ther 252: 410418.
  • Invernizzi RW, Garattini S (2004). Role of presynaptic alpha2-adrenoceptors in antidepressant action: recent findings from microdialysis studies. Prog Neuropsychopharmacol Biol Psychiatry 28: 819827.
  • Invernizzi RW, Parini S, Sacchetti G, Fracasso C, Caccia S, Annoni K et al. (2001). Chronic treatment with reboxetine by osmotic pumps facilitates its effect on extracellular noradrenaline and may desensitize α2-adrenoceptors in the prefrontal cortex. Br J Pharmacol 132: 183188.
  • King VM, Marsden CA, Fone KC (2008). A role for the 5-HT1A, 5-HT4 and 5-HT6 receptors in learning and memory. Trends Pharmacol Sci 29: 482492.
  • Lanni C, Govoni S, Lucchelli A, Boselli C (2009). Depression and antidepressants: molecular and cellular aspects. Cell Mol Life Sci 66: 29853008.
  • Le Poul E, Laaris N, Doucet E, Laporte AM, Hamon M, Lanfumey L (1995). Early desensitization of somato-dendritic 5-HT1A autoreceptors in rats treated with fluoxetine or paroxetine. Naunyn Schmiedebergs Arch Pharmacol 352: 141148.
  • Licht CL, Marcussen AB, Wegener G, Overstreet DH, Aznar S, Knudsen GM (2009). The brain 5-HT4 receptor binding is down-regulated in the Flinders Sensitive Line depression model and in response to paroxetine administration. J Neurochem 109: 13691374.
  • Lucas G, Debonnel G (2002). 5-HT4 receptors exert a frequency-related facilitatory control on dorsal raphé nucleus 5-HT neuronal activity. Eur J Neurosci 16: 817822.
  • Lucas G, Compan V, Charnay Y, Neve RL, Nestler EJ, Bockaert J et al. (2005). Frontocortical 5-HT4 receptors exert positive feedback on serotonergic activity: viral transfections, subacute and chronic treatments with 5-HT4 agonists. Biol Psychiatry 57: 918925.
  • Lucas G, Rymar VV, Du J, Mnie-Filali O, Bisgaard C, Manta S et al. (2007). Serotonin(4) (5-HT(4)) receptor agonists are putative antidepressants with a rapid onset of action. Neuron 55: 712725.
  • Mateo Y, Fernández-Pastor B, Meana JJ (2001). Acute and chronic effects of desipramine and clorgyline on alpha(2)-adrenoceptors regulating noradrenergic transmission in the rat brain: a dual-probe microdialysis study. Br J Pharmacol 133: 13621370.
  • Millan MJ, Dekeyne A, Papp M, La Rochelle CD, MacSweeny C, Peglion JL et al. (2001). S33005, a novel ligand at both serotonin and norepinephrine transporters: II. Behavioral profile in comparison with venlafaxine, reboxetine, citalopram, and clomipramine. J Pharmacol Exp Ther 298: 581591.
  • Mostany R, Valdizan EM, Pazos A (2008). A role for nuclear β-catenin in SNRI antidepressant-induced hippocampal cell proliferation. Neuropharmacology 55: 1826.
  • Muth EA, Haskins JT, Moyer JA, Husbands GE, Nielsen ST, Sigg EB (1986). Antidepressant biochemical profile of the novel bicyclic compound Wy-45,030, an ethyl cyclohexanol derivative. Biochem Pharmacol 35: 44934497.
  • Nadgir SM, Malviya M (2008). In vivo effect of antidepressants on [3H]paroxetine binding to serotonin transporters in rat brain. Neurochem Res 33: 22502250.
  • Parini S, Renoldi G, Battaglia A, Invernizzi RW (2005). Chronic reboxetine desensitizes terminal but not somatodendritic alpha2-adrenoceptors controlling noradrenaline release in the rat dorsal hippocampus. Neuropsychopharmacology 30: 10481055.
  • Pascual-Brazo J, Pilar-Cuellar F, Ruíz I, Martín A, Pazos A, Valdizán E et al. (2009). Neuroplastic changes associated to antidepressant efficacy after a short treatment with a 5-HT4 receptor agonist. Society for Neurosciences Abstract, Chigaco, USA. Program No. 549.15.
  • Paxinos G, Watson C (1982). The Rat Brain in Stereotaxic Coordinates. Academic Press: Sydney.
  • Pejchal T, Foley MA, Kosofsky BE, Waeber C (2002). Chronic fluoxetine treatment selectively uncouples raphe 5-HT(1A) receptors as measured by [(35)S]-GTP gamma S autoradiography. Br J Pharmacol 135:11151122.
  • Ray AM, Kelsell RE, Houp JA, Kelly FM, Medhurst AD, Cox HM et al. (2009). Identification of a novel 5-HT(4) receptor splice variant (r5-HT(4c1)) and preliminary characterisation of specific 5-HT(4a) and 5-HT(4b) receptor antibodies. Eur J Pharmacol 604: 111.
  • Rosel P, Arranz B, Urretavizcaya M, Oros M, San L, Navarro MA (2004). Altered 5-HT2A and 5-HT4 postsynaptic receptors and their intracellular signalling systems IP3 and cAMP in brains from depressed violent suicide victims. Neuropsychobiology 49: 189195.
  • Schechter LE, Ring RH, Beyer CE, Hughes ZA, Khawaja X, Malberg JE (2005). Innovative approaches for the development of antidepressant drugs: current and future strategies. NeuroRx 2: 590611.
  • Schildkraut JJ (1965). The catecholamine hypothesis of affective disorders: a review of supporting evidence. Am J Psychiatry 122: 509522.
  • Tamburella A, Micale V, Navarria A, Drago F (2009). Antidepressant properties of the 5-HT4 receptor partial agonist, SL65.0155: behavioral and neurochemical studies in rats. Prog Neuropsychopharmacol Biol Psychiatry 33: 12051210.
  • Tokarski K, Bijak M (1996). Antidepressant-induced adaptive changes in the effects of 5-HT, 5-HT1A and 5-HT4 agonists on the population spike recorded in hippocampal CA1 cells do not involve presynaptic effects on excitatory synaptic transmission. Pol J Pharmacol 48: 565573.
  • Valdizán EM, Gutierrez O, Pazos A (2003). Adenylate cyclase activity in postmortem brain of suicide subjects: reduced response to β-adrenergic stimulation. Biol Psychiatry 54: 14571464.
  • Valdizán EM, Castro E, Pazos A (2009). Agonist-dependent modulation of G protein coupling and transduction of 5-HT1A receptors in rat dorsal raphe nucleus. Int J Neuropsychopharmacol [Epub ahead of print.
  • Vetulani J, Nalepa I (2000). Antidepressants: past, present and future. Eur J Pharmacol 405: 351363.
  • Vidal E, Valdizan EM, Mostany R, Pazos A, Castro E (2009). Long-term treatment with fluoxetine induces desensitization 5-HT4 receptor-dependent signalling and functionality in rat brain. J Neurochem 110: 11201127.
  • Vilaró MT, Wiederhold K-H, Palacios JM, Mengod G (1992). Muscarinic M2 receptor mRNA expression in cholinergic and non-cholinergic cells in the rat brain: a correlative study using in situ hybridization histochemistry and receptor autoradiography. Neuroscience 47: 367393.
  • Vilaró MT, Cortés R, Gerald C, Branchek TA, Palacios JM, Mengod G (1996). Localization of 5-HT4 receptor mRNA in rat brain by in situ hybridization histochemistry. Brain Res Mol Brain Res 43: 356360.
  • Vilaró MT, Cortés R, Mengod G (2005). Serotonin 5-HT4 receptors and their mRNAs in rat and guinea pig brain: distribution and effects of neurotoxic lesions. J Comp Neurol 484: 418439.
  • Waeber C, Sebben M, Nieoullon A, Bockaert J, Dumuis A (1994). Regional distribution and ontogeny of 5-HT4 binding sites in rodent brain. Neuropharmacology 33: 527541.
  • Yamaguchi T, Suzuki M, Yamamoto M (1997). Facilitation of acetylcholine release in rat frontal cortex by indeloxazine hydrochloride: involvement of endogenous serotonin and 5-HT4 receptors. Naunyn Schmiedebergs Arch Pharmacol 356: 712720.